ACME Lab recommends 35pc cash div

Dhaka,  Monday,   2016-09-21
Published : 21 Sep 2016, 10:31:46

ACME Lab recommends 35pc cash div

FE Online Report
The board of directors of ACME Laboratories has recommended 35 per cent cash dividend for the year ended on June 30, 2016, said an official disclosure. The final approval will come during the annual generation meeting (AGM) scheduled to be held on November 7 at 10:30am at PSC Convention Hall, Mirpur in Dhaka.

The record date for entitlement of cash dividend is on October 13.

The company has reported earnings per share (EPS) of Tk 6.55, net asset value (NAV) per share of Tk 77.34 and net operating cash flow per share (NOCFPS) of Tk 6.25 for the year ended on June 30, 2016 as against Tk 5.70, Tk 70.37 and Tk 6.50 respectively for the same period of the previous year.

There will be no price limit on the trading of the shares of the company today (Wednesday) following its corporate declaration.

The country’s oldest pharmaceutical company’s share price hovered between Tk 109.70 and Tk 112.80 on Tuesday, before closing at Tk 111.50 each, shedding 1.26 per cent over the day before.

ACME Laboratories, which was listed on the stock exchanges in June this year, recommended the first dividend after listing.

ACME’s paid-up capital is Tk 2,116.02 million and authorised capital is Tk 5,000 million, while the total number of securities is 211,601,700.

The company’s total market cap stood at Tk 23,551.27 million as on Tuesday.

The sponsor-directors own 38.88 per cent stake in the ACME, while institutional investors own 23.88 per cent, foreign investors 0.73 per cent and the general public 36.51 per cent as on July 31, 2016, the DSE data showed.


Editor : A.H.M Moazzem Hossain
Published by the Editor for International Publications Limited from Tropicana Tower (4th floor), 45, Topkhana Road, GPO Box : 2526 Dhaka- 1000 and printed by him from City Publishing House Ltd., 1 RK Mission Road, Dhaka-1000.
Telephone : PABX : 9553550 (Hunting), 9513814, 7172017 and 7172012 Fax : 880-2-9567049
Email :,
Copyright © 2016. All rights reserved
Powered by : orangebdlogo